viimane versioon :
22/08/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Carmustine
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Becenun
Brasiilia
Bicnu
Ameerika ühendriigid, Austraalia, Hispaania, Iirimaa, Iraan, Kanada, Kolumbia, Kreeka, Maroko, Maroko, Mehhiko, Prantsusmaa, Rumeenia, Suurbritannia, Sveits, Tšiili, Tuneesia, Ungari, uus-Meremaa
Bodacler
Argentiina
Carmubris
Austria, Iraan, Saksamaa
Carmustina Grey
Maroko
Carmustina Perulab
Maroko
Carmustine Baxter
uus-Meremaa
Carmustine Obvius
Austria, Belgia, Bulgaaria, Hispaania, Holland, Horvaatia, Iirimaa, Island, Luksemburg, Norra, Poola, Portugal, Prantsusmaa, Rootsi, Rumeenia, Saksamaa, Slovakkia, Sloveenia, Soome, Suurbritannia, Taani, Tšehhi, Ungari
Nitrourean
Hispaania
Nitrumon
Belgia, Iraan, Luksemburg
Viited : Carmustine
tüüp
avaldamine
3
ajaleht
Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
81
ajaleht
Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84
ajaleht
Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
99
ajaleht
Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
146
ajaleht
Hadji-Minaglou-Gonzalvez MF, Gayte-Sorbier A, Airauto CB, Verdier M.
Effects of temperature, solution composition, and type of container on the stability and absorption of carmustine.
Clin Ther 1992 ; 14: 821-824.
169
ajaleht
Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182
ajaleht
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244
ajaleht
Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
249
ajaleht
Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
307
ajaleht
Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
334
ajaleht
Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335
ajaleht
Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
492
ajaleht
Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
715
ajaleht
Colvin M, Hartner J, Summerfield M.
Stability of carmustine in the presence of sodium bicarbonate.
Am J Hosp Pharm 1980 ; 37: 677-678.
837
ajaleht
Fredriksson K, Lundgren P, Landersjo L.
Stability of carmustine - kinetics and compatibility during administration.
Acta Pharm Suec 1986 ; 23: 115-124.
905
ajaleht
Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
1410
ajaleht
Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1423
ajaleht
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1501
ajaleht
Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M.
Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials.
Int J Pharm 1999 ; 185: 113-121.
1520
Labor
Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
1622
ajaleht
Favier M, De Casanove F, Coste A, Cherti N, Bressolle F.
Stability of carmustine in polyvinyl chloride bags and polyethylene-lined trilayer plastic containers.
Am J Health-Syst Pharm 2001 ; 58: 238-241.
2146
ajaleht
Trissel LA, Xu QA, Baker M.
Drug compatibility with new polyolefin infusion solution containers.
Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
3314
Labor
Carmustine (Bicnu®) – Résumé des caractéristiques du produits
Bristol Myers Squibb 2011
4762
ajaleht
Knoll L, Kraemer I, Thiesen J.
Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature
EJHP 2023 ; 30, 1: 11-16.
Mentions Légales